The new Novavax Covid-19 vaccine will be available later this year

There are many indications that another vaccine against Covid-19 will be approved for mass production and global distribution later this year. The US company Novavax Inc has announced that Phase 3 trials are now underway for a new vaccine that is 90% effective against a range of different variants of the coronavirus.